Sponsor ICCN
80,000+ monthly content views across Substack, LinkedIn, and the ICCN ecosystem. A trusted, clinician-led audience of respiratory therapists, intensivists, nurses, and APPs — reached daily.
Audience by the Numbers
Why ICCN
Written by a working FCCM-credentialed clinician at Columbia — not an agency or content team. The audience trusts the source.
Sponsors are clearly disclosed and never disguised as editorial. The trust this protects is exactly what makes sponsored content perform here.
Read by the entire ICU team — RTs, MDs, RNs, APPs — not a single role. Your message reaches the full bedside workflow.
ICCN publishes seven days a week. Your brand becomes part of the routine, not a once-a-year conference moment.
Every claim is cited. Sponsors operating in regulated categories benefit from sitting next to content of unimpeachable accuracy.
Substack, LinkedIn, web. Same audience, multiple surfaces — reach clinicians where they actually consume content.
Sponsorship Tiers
Annual commitments save 17%. Founding partners (first six) lock in 2026 rates through 2027.
Test the audience.
Annual: $15,000 · save $3,000
Best for: companies testing the audience, conference organizers, single launches
Start SilverBuild category presence.
Annual: $45,000 · save $9,000
Best for: medical devices, specialty pharma, CME providers, EHR/CDS tools
Start GoldFull editorial integration.
Annual: $125,000 · save $25,000
Best for: ventilator/monitor OEMs, pharma launches, CME, conference organizers, EHR vendors
Start PlatinumAll placements clearly labeled as sponsored. Editorial control of clinical content remains with ICCN. À la carte, single-issue, and multi-quarter bundles available — ask about a custom package.
Get in Touch
Sponsorships are limited — we cap partners per editorial track to preserve audience trust. Send an inquiry and we’ll respond within two business days with a custom proposal.
Or download the full prospectus and bring it to your team:
Reach Out Directly
For partnership inquiries, custom packages, and category exclusivity questions.